Researchers: Veronica Galvan, Matthew J Hart
Aging is the strongest known risk factor for Alzheimer’s disease (AD). With the discovery of the mechanistic target of rapamycin (mTOR) as a critical pathway controlling the rate of aging in mice, molecules at the interface between the regulation of aging and the mechanisms of specific age-associated diseases can be identified. We will review emerging evidence that mTOR-dependent brain vascular dysfunction, a universal feature of aging, may be one of the mechanisms linking the regulation of the rate of aging to the pathogenesis of Alzheimer’s disease. This article is part of a Special Issue entitled: Vascular Contributions to Cognitive Impairment and Dementia edited by M. Paul Murphy, Roderick A. Corriveau and Donna M. Wilcock.
References
- Lessons on longevity from budding yeast.
- Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice.
- Cellular and molecular biology of aging endothelial cells.
- Promoting health and longevity through diet: from model organisms to humans.
- FoxO.
- The mitochondrial uncoupler DNP triggers brain cell mTOR signaling network reprogramming and CREB pathway up-regulation.